Die ECD Global Alliance vergibt ein Forschungsstipendium zur Erdheim-Chester-Krankheit an das MSKCC, um die krankheitsauslösende Zellpopulation bei ECD zu identifizieren und genetische Veränderungen zu vergleichen.
The ECD Global Alliance welcomes Duke Cancer Institute in Durham, NC into the referral care center network that serves ECD patients worldwide. Richard F. Riedel, MD will be leading the institute’s team at the Emerging Referral Care Center.
The ECD Global Alliance announces the launch of the Registry for Patients with Erdheim-Chester Disease led by Memorial Sloan Kettering Cancer Center (MSK), in New York, NY. The next step in building the registry database includes recruiting patients with ECD to...
Medical residents and physicians at Houston Methodist Hospital in Houston, TX learned about Erdheim-Chester disease from ECD Care Center lead, Mark Heaney, MD, PhD from Columbia University Medical Center. Also in attendance was ECDGA President, Kathy Brewer.
Die „Erdheim-Chester Disease Global Alliance“ begrüßt das „Stanford Histiocytosis Program“ bei Stanford Health Care als neuestes „ECD Emerging Care Center“.
